Background {#Sec1}
==========

*Vibrio* spp. that have been associated with diseases in animals and human often possess virulence factors, which are not available or present in the environmental *Vibrio* \[[@CR1]\]. However, since *Vibrio* possesses highly plastic genome, the probability of horizontal transfer of the virulence genes between pathogenic and environmental *Vibrio* is high. This contributes to the increased number of pathogenic *Vibrio* strains in aquatic environment \[[@CR2]\]. Recently, more disease outbreaks following infections by *Vibrio harveyi*, *V. alginolyticus, V. parahaemolyticus* and *V. campbellii* in farmed fishes were reported in many tropical countries \[[@CR3]--[@CR6]\].

Several extracellular products that are known to contribute to the virulence of *Vibrio* include proteases, hemolysins, phospholipases, siderosphores, cytotoxins, biofilm formation, quorum sensing, and presence of phage \[[@CR7]--[@CR9]\]. Swarming motility of *Vibrio* has been consistently associated with their virulence \[[@CR10]\], while hemolysin is a common virulence factor reported in *Vibrio* associated with both fish and human diseases \[[@CR11]\]. In addition, virulence of several pathogenic *Vibrio* has also been attributed to quorum-sensing, the bacterial cell to cell communication \[[@CR12]\].

Resistance to the bactericidal mechanisms is another important contributor to the virulence of fish pathogen. In the past few decades, antimicrobial resistance has emerged and evolved in *Vibrio* spp. due to the excessive use of antibiotics in human medicine, agriculture and aquaculture systems \[[@CR13]\]. This issue gained great concern due to the increased resistance of pathogenic *V. parahemolyticus*, *V. harveyi* and *V. vulnificus* towards many clinically used antimicrobials \[[@CR14]--[@CR18]\]. Moreover, multiple antibiotic resistance (MAR) strains of *V. harveyi* and *V. alginolyticus* have caused severe economic setbacks to the aquaculture industry \[[@CR19]\].

This study described the presence of virulence-associated genes and antibiotic resistance patterns of *Vibrio* spp. within the *Harveyi* clade, which were isolated from various aquaculture areas in Peninsular Malaysia. Three typical virulence genes that were possessed by *V. harveyi* (*chiA*, *luxR* and *vhpA*) and five atypical virulence genes that contributed to pathogenic *Vibrio* of both fish and human (*flaC*, *hlyA*, *toxR*~*vc*~, *tdh* and *trh*) were targeted. Furthermore, thermolabile hemolysin gene *tlh*, a species specific marker for *V. parahaemolyticus* was also included. In addition, resistance of the isolates towards 16 commercial antibiotics of various groups were determined to evaluate the potential responsiveness to the suite of antibiotic treatments that most frequently used in aquaculture.

Results {#Sec2}
=======

Generally, five out of the nine targeted virulence genes were present in the tested isolates (Fig. [1](#Fig1){ref-type="fig"}a). All (100%) 63 isolates of *Harveyi* clade possessed typical virulence genes of *chiA* and *luxR*. Forty-two isolates (67%) of studied *Harveyi* clade and all (100%) *V. campbellii* isolates were positive of *vhpA* gene. However, only two out of six virulence genes were detected in other *Vibrio* spp. tested in this study. The *tlh* was detected in all isolates except an isolate of *V. campbellii*.Fig. 1The distribution pattern of virulence genes in isolates of *Harveyi* clade in this study. (**a**) The presence (blue dot) and the absence (grey dot) of target genes in *Vibrio* isolates according to their species; (**b**) The summary of *Vibrio* spp. positive with *chiA*, *luxR*, *vhpA*, *tlh* and *flaC*

The *flaC* gene was detected in 68% of the isolates (Fig. [1](#Fig1){ref-type="fig"}b). All *V. harveyi* and *V. parahaemolyticus* that were isolated from Pulau Ketam were positive for *flaC*. However, they lack the *tdh*, *trh*, *hlyA* and *toxR*~vc~ genes. Moreover, 27 (43%) of the isolates carried all the virulence genes of *chiA*, *luxR*, *vhpA*, *flaC* and *tlh*, including all *V. campbellii* that were isolated from Pulau Ketam, and two *V. parahaemolyticus* from Banting. However, there was no correlation between the presence of virulence genes and the source of the isolates.

Amplification of *chiA*, *luxR*, *vhpA*, *flaC* and *tlh* from all species of *Vibrio* isolates, yielded products of approximately 232 bp, 618 bp, 201 bp, 580 bp, and 450 bp, respectively (Fig. [2](#Fig2){ref-type="fig"}). Figure [3](#Fig3){ref-type="fig"} shows the phylogenetic tree of the virulence genes. Sequence analysis revealed that the *chiA* of *V. campbellii* GRO 230-L1 and *V. harveyi* SNA 143-L1 shared 99 and 89% similarity, respectively with *chiA* of *V. harveyi*, while *V. alginolyticus* SEA 124-S and *V. parahaemolyticus* GRO 286-E1 showed 95--99% similarity with chitinase A from *V. parahaemolyticus* \[AF323471\]. The *luxR* of *V. harveyi* SEA 131-K1, *V. campbellii* SEA 178-K1 and *V. parahaemolyticus* GRO 180-K1 were \> 98% similar with *luxR* of *V. harveyi*. However, *luxR* of *V. alginolyticus* SNA 212-S1 was identical (99%) to *luxR* of *V. alginolyticus* \[EF596781\]. All *vhpA* in this study shared high similarity (\> 98%) with *vhpA* of *V. harveyi*. Similarly, high similarity (\> 89%) was also observed between *tlh* of *Vibrio* isolates in this study and *tlh* of *V. parahaemolyticus* JPW-8-11-1. In addition, *flaC* of *V. harveyi* SNA 143-L1 and *V. alginolyticus* GRO 144-E1 were highly identical (99%) with *flaA* of *V. alginolyticus* HY9901. On the other hand, *flaC* of *V. parahaemolyticus* shared 99% similarity with *flaA* of *V. parahaemolyticus* ATCC 17802, while *flaC* of *V. harveyi* SNA 143-L1 shared 96% with *flaB* of *V. harveyi* VIB645.Fig. 2Presence of the *chiA*, *luxR*, *vhpA* and *flaC* of *V. anguillarum* and *tlh* of *V. parahaemolyticus* in isolates of *Harveyi* clade. Lane M: 1 kb DNA ladder; Lane 1: *chiA* (232 bp); Lane 2: *luxR* (618 bp); Lane 3: *vhpA* (201 bp); Lane 4: *flaC* (580 bp) and Lane 5: *tlh* (450 bp)Fig. 3Neighbour-joining tree (Kimura 2-parameter model) of (**a**) *chiA* (**b**) *luxR* (**c**) *vhpA* (**d**) *flaC* (**e**) *tlh* gene sequences from representative *Vibrio* isolates in this study. Reference sequences acquired from the NCBI GenBank are marked with their accession numbers. Strains in blue colour served as outgroup

The antibiotic resistance patterns are illustrated in Fig. [4](#Fig4){ref-type="fig"}. Highest resistance (79 to 99%) was observed against penicillin and the polypeptides group of antibiotics. All *Vibrio* spp. isolated from Pulau Ketam, with the exception of one isolate of *V. alginolyticus* and *V. harveyi* were resistance against AMP, P and VA. This was also exhibited by all *V. campbellii* isolates, regardless of their geographical origin. On the other hand, sensitivity towards AMP was mostly observed in *V. parahaemolyticus* isolated from Perak, Kedah, Kelantan and Johor. High resistance towards E was also observed in this study, where only 9% of the isolates showed sensitivity towards E.Fig. 4Antibiotic resistance patterns showed by isolates of *Harveyi* clades isolated from sampled fishes. MAR index (MARi) indicated the multiple antibiotics resistance index for the isolates. AMP: Ampicillin (10 μg), P: Penicillin G (10 unit), CTX: Cefotaxime (30 μg), FEP: Cefepime (30 μg), KF: Cephalothin (30 μg), CN: Gentamycin (10 μg), K: Kanamycin (30 μg), S: Streptomycin (10 μg), TE: Tetracycline (30 μg), CIP: Ciprofloxacin (5 μg), NA: Nalidixic acid (30 μg), F: Nitrofurantoin (300 μg), SXT: Sulfamethoxazole/trimethoprim (1.25/23.75 μg), C: Chloramphenicol (30 μg), E: Erythromycin (15 μg), VA: Vancomycin (30 μg)

A total of 60 and 46% of isolates were resistance against at least one antibiotic from cephems and aminoglycosides groups. Lower resistance level was observed for CN, K and FEP, with less than 6% resistant isolates. However, more than 40% of the tested isolates were resistant against CTX, KF and S. The resistance against CTX was mostly showed by *V. campbellii* (78%), followed by *V. harveyi* (63%) and *V. alginolyticus* (62%). Low resistance (8%) towards quinolones group of antibiotic was observed in this study where none of *V. alginolyticus* and *V. harveyi* isolate was resistant towards CIP and NA. In addition, only one and seven isolates were resistant to C and SXT, respectively. None of the isolate in this study was resistant against F and TE.

The MAR index denotes the extent of environmental contamination by antimicrobial agents which potentially harmful to human health \[[@CR20]\]. A MAR index higher than 0.2 indicated high-risk exposure to antibiotics. In this study, the MAR index ranged between 0.06 and 0.56. Approximately 75% of the isolates showed MAR index of higher than 0.20, including 80% from Pulau Ketam. However, no clear pattern was observed between the MAR index and the geographical origin. Nevertheless, an isolate of *V. harveyi* and two isolates of *V. parahaemolyticus* showed resistance against the nine antibiotics tested, with MAR index of 0.56. Among the three isolates, *V. parahaemolyticus* (GRO 286-E1) isolated from Pulau Ketam exhibited strongest resistance towards antibiotics tested, where only two antibiotics (TE and F) can inhibit the growth of this isolate.

Discussion {#Sec3}
==========

This study examines two factors that contribute to the pathogenicity of *Vibrio* spp., which previously isolated from cultured marine fishes in selected important farms and hatcheries in Peninsular Malaysia; the presence of virulence genes associated with pathogenic strains and the antibiotics resistance of *Vibrio* spp.

Virulence genes including *chiA*, *luxR*, *toxR*~*vh*~, *vhpA*, serine protease and *vhh* were widely distributed among pathogenic *V. harveyi* \[[@CR21]\]. The distribution of these virulence genes in the closely related species of *V. harveyi* has also been documented \[[@CR7]\]. In agreement to previous studies, *chiA* and *luxR* were found to presence in all isolates of *Harveyi* clade analysed in present study.

On the other hand, typical virulence gene of *vhpA* was observed in \> 50% of the isolates in this study, with 100% prevalence in *V. campbellii* isolates. Even though *vhpA* was reported as a typical virulence gene harboured by *V. harveyi*, only 50% of our *V. harveyi* isolates was positive for this gene. Ruwandeepika et al. \[[@CR21]\], reported a 100% prevalence of *vhpA* among *V. harveyi* but conversely, *vhpA* was reported to be absent in all *V. harveyi* isolated from diseased cultured fish in China, regardless of the virulence level \[[@CR2], [@CR19]\].

Studies demonstrated that the presence of chitinase and metalloprotease in ECP of *Vibrio* can cause disease in wide range of aquatic animals including fish, oyster and shrimp \[[@CR7], [@CR22]\]. In addition, quorum sensing was reported to regulate the production of these ECP and other virulence genes in Gram-negative fish pathogens \[[@CR12]\]. For instance, Defoirdt \[[@CR23]\] described on the virulence of *V. harveyi* controlled by quorum sensing. Another study by Croxatto et al. \[[@CR24]\] demonstrated the involvement of quorum sensing in the secretion of metalloprotease *EmpA* and biofilm formation in *V. anguillarum*.

In this study, *flaC* was widely distributed in 60% of *V. alginolyticus*, 63% of *V. parahaemolyticus*, and 78% *V. campbellii* isolates. In addition, all *V. harveyi* harboured *flaC* gene. In a study conducted by Bai et al. \[[@CR25]\], 37.5% of the *V. harveyi* isolates carried the *flaC* gene. They also reported that the *flaC* gene was widely distributed in other *Vibrio* spp. including *V. anguillarum*, *V. alginolyticus*, *V. campbellii*, *V. fischeri*, *V. fluvialis*, *V. mimicus*, *V. natriegens* and *V. parahaemolyticus*. Another study revealed that *flaC* was detected in 60% of the *Vibrio* in the *Harveyi* clade \[[@CR21]\]. Similarly, the sequence diversity of *flaC* observed in this study coincided with a previous report \[[@CR25]\], and flagella play an important role in infecting host because it increase the motility of bacteria for colonization, or act as adhesive component \[[@CR26]\].

The thermolabile hemolysin gene *tlh* was previously used as species specific marker to identify *V. parahaemolyticus* \[[@CR27]\]. However in this study, *tlh* recovered from non-*parahaemolyticus* strains showed highly similar sequence with those from *V. parahaemolyticus*. The results indicate that *tlh* cannot be used as species specific marker for detection of *V. parahaemolyticus* due to possible detection of false-positive results. Furthermore, previous study showed an increase in the environmental *V. parahaemolyticus* strains carrying the *tdh* and/or *trh* genes in Malaysia \[[@CR28]\]. Interestingly, all isolates in this study lacked the virulence genes associated pathogenic *Vibrio* of human*,* which are the *tdh*, *trh*, *hlyA* and *toxR*~*vc*~ genes, indicating low potential risk for human health. On the other hand, higher percentage of pathogenic *Vibrio* were positive to *trh* (40%) and *tdh* (12.3%) was detected in aquatic animals in other studies \[[@CR29], [@CR30]\].

In general, similar virulence genes were widely distributed in the *Harveyi* clade, indicating that the genes are readily transferred among the Vibrionaceae species. This horizontal transferability of virulence genes might be due to their survival benefits in a variety of environments and host organisms \[[@CR31]\].

Antibiotics are commonly used in fish farms either as feed additives, prophylaxis or therapy. Oxytetracycline, TE, quinolones, nitrofurans, potentiated sulfonamides, trimethoprim, sarafloxacin, flumequine and oxolinic acid are among the permissible antibiotics that have been used to combat vibriosis \[[@CR32]\]. This study revealed that the *Harveyi* clade were highly resistance to AMP and VA. Similarly, all *Vibrio* isolates collected from Malaysian coastal area were resistant to AMP at the rate between 42 and 82% \[[@CR33]\], including 100% of isolates from farmed fish \[[@CR34]\]. The prevalence of AMP resistance in *Vibrio* isolates from marine environment is generally high, which probably due to the wide usage of AMP. Moreover, resistance to AMP or other penicillin were also well documented from environmental isolated *Vibrio*, ranging from 56 to 100% in China, Italy and U.S. \[[@CR19], [@CR35], [@CR36]\].

FEP is one of the newer fourth generation cephalosporins \[[@CR33]\]. While none of the isolates in this study showed resistance towards FEP, 84% of the isolates showed immediate sensitive towards this antibiotic. On the other hand, TE and nitrofurans were effective to inhibit the growth of *Vibrio* isolates in this study, thus can be used to treat *Vibrio* infection in Malaysian farm. However, prolonged and misused of antibiotics possess the danger of developing antibiotic resistant genes, that cause the *Vibrio* to develop resistance \[[@CR13]\].

In this study, the prevalence of MAR strains of *Vibrio* was at the alarming rate. The results indicate that the MAR strains of *Vibrio* existed widely in the aquaculture farm in this country. Ransangan et al. \[[@CR34]\] and You et al. \[[@CR33]\] reported high prevalence of multiple antibiotic *Vibrio* recovered from coastal seawater in Malaysia. While there is limited documentation on the information of the use of antibiotics in Malaysian fish farming, emergence of MAR *Vibrio* strains due to excessive utilization of antibiotics has been reported in other countries \[[@CR2], [@CR19], [@CR37], [@CR38]\]. For example, high MAR index (0.4) of *Harveyi* clade strains causing scale drop and muscle necrosis disease in groupers was reported in China \[[@CR19]\]. Moreover, 77.3% of *V. parahaemolyticus* isolated from oyster in Korea demonstrated MAR to at least three antibiotics, with highest MAR index of 0.75 in one isolate \[[@CR18]\].

In general, high prevalence of isolates that were resistant to multiple antibiotics was observed in Pulau Ketam, one of the extensive mariculture farms in Malaysia. While no antibiotic was recorded being used for treatment at our sampling site in Pulau Ketam, the *Vibrio* with multiple antibiotic resistance can be easily transmitted from nearby farms that used antibiotic via water column. In addition, *Vibrio* spp. may acquire and carry antibiotic resistance genes by horizontal genetic transference from and to neighbouring microorganisms. Out of seven sampling site, only the hatchery in Port Dickson reported on the utilization of antibiotic to treat bacterial infection. The rapid increase in antibiotic resistance rendered the treatment to be more difficult. The use of antibiotics in aquaculture also impacts the frequencies of resistance in human pathogens \[[@CR15], [@CR37]\]. Therefore, calls for the reduction of antibiotic use has been done worldwide \[[@CR38], [@CR39]\].

Other methods of vibriosis control are urgently needed. In recent year, the disruption of quorum sensing has recently been suggested as a cost-effective and environmental friendly method \[[@CR12]\]. Several bacteria, micro-algae, macro-algae and aquatic sponges have been shown to inhibit quorum sensing properties in pathogenic *Vibrio* particularly *V. harveyi* \[[@CR12], [@CR23]\]. Given the wide distribution of quorum sensing regulated-gene in different *Vibrio* species found in this study, this method are promising to control the expression of virulence factors by different *Vibrio* species in aquaculture. In addition, immunostimulants, bacteriophage, vaccines and probiotics also have potentials to replace antibiotics in controlling and preventing vibriosis in fish farm \[[@CR40]\].

Conclusion {#Sec4}
==========

In conclusion, low prevalence of virulence genes was detected in *Vibrio* spp. within the *Harveyi* clade in this study. However, majority of the isolates exhibited multiple resistance to tested antibiotics, highlighting the urgency for reducing the usage of antibiotic in fish farms. It is necessary to perform extensive studies on the spread of antibiotic resistance genes in *Vibrio* to understand the potential risk to public health. In the meantime, alternative non-antibiotic based methods such as quorum quenching and utilization of lytic bacteriophage for preventing and treating bacterial infections in fish farm are needed.

Methods {#Sec5}
=======

Bacterial strains {#Sec6}
-----------------

Large collection of *Vibrio* strains previously isolated from either healthy or diseased fish cultured in marine farm or hatchery were used in this study. The farm and hatchery included were intensive or semi-intensive farms culturing and producing finfish fry, including Asian seabass (*Lates calcarifer*), red snapper (*Lutjanus* sp.) and hybrid grouper (*Epinephelus* sp.). Seven sampling sites were selected as representative of important fish farming and fry producing area in Peninsular Malaysia; Pulau Ketam and Banting in Selangor, Port Dickson in Negeri Sembilan, Kuala Gula in Perak, Kukup in Johor, Kota Bharu in Kelantan, and Pulau Langkawi in Kedah (Table [1](#Tab1){ref-type="table"}).Table 1Number of *Vibrio* isolates, type and background information of farms and hatcheries selected in this studyLocationNo. of *Vibrio* isolatesType of sampling sitesDiseases problem encounteredTreatments historySpecies of cultured fishStocking densityVAVPVHVCTotalPulau Ketam, Selangor2168540FarmBacteria, virus, parasiteChemicalRed snapper, hybrid grouper, Asian seabass, golden pompano300 fish/cageKuala Gula, Perak33--17FarmBacteria, parasiteChemicalRed snapper, hybrid grouper, Asian seabass300 fish/cagePort Dickson, Negeri Sembilan22--26HatcheryBacteria, virusChemical, antibioticHybrid grouper400 fish/tankPulau Langkawi, Kedah11----2FarmBacteria, virusChemicalHybrid grouper1500 fish/cageBanting, Selangor--2----2HatcheryBacteriaChemicalHybrid grouperNAKota Bharu, Kelantan--3--14HatcheryBacteriaChemicalHybrid grouperNAKukup, Johor--2----2FarmParasiteFreshwaterHybrid grouper1000 fish/cage*VA Vibrio alginolyticus*, *VP Vibrio parahaemolyticus*, *VH Vibrio harveyi*, *VC Vibrio campbellii*; −: no isolate, *NA* data not available

Identification of the *Vibrio* isolates were verified based on the partial sequencing of *pyrH* as described in previous reports \[[@CR41], [@CR42]\]. Based on the recovery rates, only four species of *Vibrio* were selected for this study. A total of 63 isolates representative of *V. alginolyticus*, *V. harveyi*, *V. parahaemolyticus* and *V. campbellii* were analysed. Forty of the isolates were isolated either from Asian seabass, red snapper and hybrid grouper cultured in Pulau Ketam, Selangor. Another 23 *Vibrio* isolates were recovered from hybrid groupers cultured in farm or hatchery located in different states in Peninsular Malaysia (Table [1](#Tab1){ref-type="table"}). The code, species name, source of isolation, clinical sign/s of the host, month and year of isolation, and geographical origin of the isolates as listed in Appendix [1](#Sec9){ref-type="sec"}. All isolates were kept in 20% glycerol stock and stored at − 80 °C for further analysis.

Virulence genes detection {#Sec7}
-------------------------

All isolates were sub-cultured from glycerol stock onto Tryptic Soy Agar (TSA) (HiMedia, Mumbai, India), supplemented with 1.5% NaCl and incubated at 30 °C for 18 h. Prior to PCR, genomic DNA of the isolates was extracted using Wizard Genomic DNA Purification Kit (Promega, WI, USA).

A total of nine virulence-associated genes (*chiA*, *vhpA, luxR*, *flaC*, *hlyA*, *toxR*~*vc*~, *tlh*, *tdh* and *trh*) of *Vibrio* were detected by PCR amplification. The sequence of primers used are as listed in Table [2](#Tab2){ref-type="table"}. PCR amplifications were performed in a final volume of 30 μL, which contained 1× PCR buffer, 2 mM MgCl2, 200 uM dNTPs, 10 pmol of forward primer, 10 pmol of reverse primer, 5 U/μL Taq polymerase and 100 ng of template DNA (Promega). The amplification was performed under the following conditions: initial denaturation at 95 °C for 5 min, followed by 30 cycles of 95 °C for 1 min; 50 °C for 1 min (*chiA*, *vhpA* and *luxR*), 55 for 1 min (*flaC*), 60 for 1 min (*hlyA* and *toxR*~*vc*~) and 72 °C for 1 min, and a final extension of 72 °C for 10 min using Eppendorf Mastercycler Nexus Thermal Cycler (Eppendorf, Hamburg, Germany). The amplification of *tlh*, *trh* and *tdh* was performed under the following conditions: initial denaturation at 94 °C for 3 min, followed by 30 cycles of 94 °C for 1 min; 58 °C for 1 min and 72 °C for 1 min, and a final extension of 72 °C for 10 min.Table 2Virulence factors, sequence of primers, references and expected amplicon size of target gene used in this studyGeneVirulence factorPrimer sequence (5′-3′)ReferenceAmplicon size (bp)*chiA*ChitinaseF: GGAAGATGGCGTGATTGACT R: GGCATCAATTTCCCAAGAGA\[[@CR21]\]232*vhpA*MetalloproteaseF: CTGAACGACGCCCATTATTT R:CGCTGACACATCAAGGCTAA\[[@CR21]\]201*luxR*Quorum sensing factorsF: ATGGACTCAATTGCAAAGAG R: TTAGTGATGTTCACGGTTGT\[[@CR21]\]618*flaC*Flagella of *V. anguillarum*F: AAATCATTCCAAATCGGTGC R: TCTTTGATTCGGCTCTTA\[[@CR25]\]580*hlyA*Haemolysin of *V. cholera*F: GGCAAACAGCGAAACAAATAC C R: CTCAGCGGGCTAATACGGTTTA\[[@CR48]\]738*toxR* ~*Vc*~Toxin of *V. cholera*F: ATG TTC GGA TTA GGA CAC R: TAC TCA CAC ACT TTG ATG GC\[[@CR49]\]883*tlh*Thermolabile haemolysin of *V. parahaemolyticus*F: AAAGCGGATTATGCAGAAGCACTG R: GCTACTTTCTAGCATTTTCTCTGC\[[@CR27]\]450*tdh*Thermostable direct haemolysin (TDH) of *V. parahaemolyticus*F: GTAAAGGTCTCTGACTTTTGGAC R: TGGAATAGAACCTTCATCTTCACC\[[@CR27]\]269*trh*TDH-related haemolysin (TRH) of *V. parahaemolyticus*F: TTGGCTTCGATATTTTCAGTATCT R: CATAACAAACATATGCCCATTTCCG\[[@CR27]\]500

Amplified PCR products were visualised on 1.2% agarose gel stained with ethidium bromide, run at 90 V for 40 min, and photographed using a gel documented system. The confirmation of the presence of genes were by partial sequencing (FirstBase, Kuala Lumpur, Malaysia) and BLAST comparison with GenBank (<http://blast.ncbi.nlm.nih.gov/>). Following multiple alignment of genes with their closed taxa by CLUSTAL W method, neighbour-joining trees were constructed using the Kimura 2-parameter model with MEGA version 7.0 with bootstraps of 1000 replicates \[[@CR43]\].

Antibiotic sensitivity testings {#Sec8}
-------------------------------

The antibiotics sensitivity of the isolates were examined by the disc diffusion methods \[[@CR44]\]. A total of 18 representative antimicrobial agents (Oxoid, London, UK), including penicillins (ampicillin (AMP): 10 μg; penicillin G (P): 10 units), cephems (cefotaxime (CTX): 30 μg; cefepime (FEP): 30 μg; cephalothin (KF): 30 μg), aminoglycosides (gentamycin (CN): 10 μg; kanamycin (K): 30 μg; streptomycin (S): 10 μg), and others such as nalidixic acid (NA): 30 μg; trimethoprim/sulfamethoxazole (SXT): 1.25/23.75 μg; chloramphenicol (C): 30 μg; nitrofurantoin (F): 300 μg; ciprofloxacin (CIP): 5 μg; tetracycline (TE): 30 μg; erythromycin (E): 15 μg; and vancomycin (VA): 30 μg were used.

Following incubation for 18--24 h, the isolates were then inoculated in sterile saline water to achieve turbidity equivalent to 0.5 MacFarland standard. The broth were evenly swabbed onto Mueller Hinton agar (HiMedia) supplemented with 1% of NaCl \[[@CR45]\]. Antibiotic discs were aseptically placed on the swabbed plates. The plates were then incubated at 35 °C for 16--18 h, and the clearing zone was recorded. Testing was confirmed in duplicate. The resistance profiles (resistant, intermediate or susceptible) were assigned using criteria described by CLSI \[[@CR44], [@CR46]\] and Bauer et al. \[[@CR47]\]. The multiple antibiotic resistance (MAR) index was determined for each isolate \[[@CR20]\]. Table [3](#Tab3){ref-type="table"} summarized the list of antibiotics and the zone diameter interpretive criteria used in this study.Table 3List of antibiotics used in this studyAntimicrobial classAntimicrobial agentCodeDoseZone diameter interpretive criteriaSensitiveIntermediateResistance*Cell envelope antibiotics* PenicillinsAmpicillinAMP10 μg≥1714--1613Penicillin GP10 unit≥2921--28≤20 CephemsCefotaximeCTX30 μg≥2619--24≤18CefepimeFEP30 μg≥2519--24≤18CephalothinKF30 μg≥1815--17≤14*Protein synthesis inhibitors* AminoglycosidesGentamycinCN10 μg≥1512--14≤11KanamycinK30 μg≥1814--17≤13StreptomycinS10 μg≥1512--14≤11 TetracyclinesTetracyclineTE30 μg≥≤*Nucleic acid inhibitors* QuinolonesCiprofloxacinCIP5 μg≥2116--20≤15Nalidixic acidNA30 μg≥1914--18≤13 DNA inhibitorsNitrofurantoinF300 μg≥1715--16≤14 Potentiated sulfonamidesSulfamethoxazole/trimethoprimSXT1.25/23.75 μg≥1611--15≤10*Phenicol derivatives* ChloramphenicolsChloramphenicolC30 μg≥1813--17≤12*Transpeptidation/Translocation* MacrolidesErythromycinE15 μg≥1814--17≤13*Glycopeptide* PolypeptidesVancomycinVA30 μg≥1210--11≤9Zone diameter interpretive criteria were referred to the performance standards proposed by Clinical and Laboratory Standards Institute \[[@CR44], [@CR46]\], with the exception for erythromycin and vancomycin which referred to Bauer et al. \[[@CR47]\]

Appendix {#Sec9}
========

Table 4Details on list of isolates used in this studyNo.CodeSpeciesSource of isolationClinical sign/s of hostMonth and year of isolationGeographical origin1SNA 92-L*V. A*Liver of red snapperRotten caudal fin, blind left eye and pale liverDec 2016Pulau Ketam, Selangor2GRO 99-E*V. A*Eye of hybrid grouperLesion on body, haemorrhagic liver and kidney and rotten caudal finDec 2016Pulau Ketam, Selangor3GRO 102-K*V. A*Kidney of hybrid grouperBlind left eye and pale liverJan 2017Pulau Ketam, Selangor4SEA 107-S*V. A*Skin mucus of Asian seabassHaemorrhagic liverJan 2017Pulau Ketam, Selangor5SNA 109-S1*V. A*Skin mucus of red snapperHaemorrhagic liver and kidneyJan 2017Pulau Ketam, Selangor6SEA 144-L*V. A*Liver of Asian seabassPale liver and haemorrhagic kidneyJan 2017Pulau Ketam, Selangor7SNA 144-L*V. A*Liver of red snapperBlind left eye, pale liver and pale kidneyFeb 2017Pulau Ketam, Selangor8GRO 144-E1*V. A*Eye of hybrid grouperLesion on body, blind left eye and haemorrhagic kidneyFeb 2017Pulau Ketam, Selangor9GRO 162-S*V. A*Skin mucus of hybrid grouperPale liverFeb 2017Pulau Ketam, Selangor10SNA 165-E*V. A*Eye of red snapperPale liverJan 2017Pulau Ketam, Selangor11GRO 198-S1*V. A*Skin lesion on hybrid grouperLesion on pectoral finApr 2017Pulau Ketam, Selangor12SNA 199-E1*V. A*Eye of red snapperNo symptomApr 2017Pulau Ketam, Selangor13SEA 205-E1*V. A*Eye of Asian seabassNo symptomMay 2017Pulau Ketam, Selangor14GRO 208-K1*V. A*Kidney of hybrid grouperLesion on all finsMay 2017Pulau Ketam, Selangor15SNA 212-S1*V. A*Skin mucus of red snapperBulging eyeMay 2017Pulau Ketam, Selangor16GRO 223-S*V. A*Skin mucus of hybrid grouperLesion on body and all fins, and haemorrhagic liverMay 2017Pulau Ketam, Selangor17SNA 226-E*V. A*Eye of red snapperHaemorrhage liverMay 2017Pulau Ketam, Selangor18SNA 266-S*V. A*Skin mucus on red snapperRotten caudal fin and pale liverMay 2017Pulau Ketam, Selangor19GRO 268-E*V. A*Eye of hybrid grouperHaemorrhagic liverMay 2017Pulau Ketam, Selangor20GRO 286-L1*V. A*Liver of hybrid grouperUlcer on body and haemorrhagic liverAug 2017Pulau Ketam, Selangor21SNA 297-S1*V. A*Skin mucus of red snapperNo symptomAug 2017Pulau Ketam, Selangor22PKG28*V. A*Spleen of hybrid grouperLesion on operculum and finsNov 2017Kuala Gula, Perak23PKGS29*V. A*Spleen of hybrid grouperLesion on operculumNov 2017Kuala Gula, Perak24PKG29*V. A*Liver of hybrid grouperLesion on operculumMar 2017Kuala Gula, Perak25NL24*V. A*Liver of hybrid grouperLesion on body and fins, and pale liverDis 2017Port Dickson, Negeri Sembilan26NS24*V. A*Spleen of hybrid grouperLesion on body and fins, and pale liverDis 2017Port Dickson, Negeri Sembilan27LL6*V. A*Liver of hybrid grouperNo symptomMar 2017Pulau Langkawi, Kedah28SNA 147-L2*V.P*Liver of red snapperHaemorrhagic liver and kidneyFeb 2017Pulau Ketam, Selangor29GRO 180-K1*V.P*Kidney of hybrid grouperNo symptomApr 2017Pulau Ketam, Selangor30SEA 196-S1*V.P*Skin lesion on Asian seabassLesion on bodyApr 2017Pulau Ketam, Selangor31GRO 251-K1*V.P*Kidney of hybrid grouperUlcer on body and fins, and pale liverJuly 2017Pulau Ketam, Selangor32SEA 252-E1*V.P*Eye of Asian seabassRotten caudal finJuly 2017Pulau Ketam, Selangor33GRO 286-E1*V.P*Eye of hybrid grouperUlcer on body and haemorrhagic liverAug 2017Pulau Ketam, Selangor34BK2G2*V.P*Kidney of hybrid grouperLesion on operculum, pale liver and enlarged spleenNov 2016Kuala Gula, Perak35BK3G2*V.P*Kidney of hybrid grouperPale liverNov 2016,Banting, Selangor36PKGL4*V.P*Liver of hybrid grouperLesion on bodyNov 2017Kuala Gula, Perak37PKGS11*V.P*Spleen of hybrid grouperNo symptomNov 2017Kuala Gula, Perak38PKGL27*V.P*Liver of hybrid grouperLesion on finsNov 2017Kuala Gula, Perak39NK6*V.P*Kidney of hybrid grouperLesion on body and fins, and pale liverDis 2017Port Dickson, Negeri Sembilan40NS8*V.P*Spleen of hybrid grouperLesion on body and finsDis 2017Port Dickson, Negeri Sembilan41LK14*V.P*Kidney of hybrid grouperNo symptomAug 2017Pulau Langkawi, Kedah42KK3*V.P*Kidney of hybrid grouperLesion on operculum, and enlarged spleen and liverSept 2017Kota Bharu, Kelantan43KL4*V.P*Liver of hybrid grouperLesion on body, and enlarged spleen and liverSept 2017Kota Bharu, Kelantan44KL17*V.P*Liver of hybrid grouperLesion on body, eye opacity, pale liver and enlarged spleenSept 2017Kota Bharu, Kelantan45JS14*V.P*Spleen of hybrid grouperNo symptomDis 2017Kukup, Johor46JS24*V.P*Spleen of hybrid grouperNo symptomDis 2017Kukup, Johor47SEA 131-K1*V.H*Kidney of Asian seabassHaemorrhagic kidney and liverFeb 2017Pulau Ketam, Selangor48SNA 143-L1*V.H*Liver of red snapperRotten caudal fin and haemorrhagic kidneyFeb 2017Pulau Ketam, Selangor49GRO 154-E1*V.H*Eye of hybrid grouperLesion on pelvic fin and severely pale liverMar 2017Pulau Ketam, Selangor50SEA 166-E*V.H*Eye of Asian seabassLesion on body and haemorrhagic liverApr 2017Pulau Ketam, Selangor51SEA 192-S1*V.H*Skin mucus of Asian seabassHaemorrhagic liverApr 2017Pulau Ketam, Selangor52GRO 200-L2*V.H*Liver of hybrid grouperNo symptomApr 2017Pulau Ketam, Selangor53SEA 207-S1*V.H*Skin mucus of Asian seabassHaemorrhagic liver and kidneyMay 2017Pulau Ketam, Selangor54SNA 272-S2*V.H*Skin mucus of red snapperPale liverJuly 2017Pulau Ketam, Selangor55SEA 178-K1*V. C*Kidney of Asian seabassHaemorrhagic liver and kidneyApr 2017Pulau Ketam, Selangor56GRO 186-K1*V. C*Kidney of hybrid grouperLesion of all finsApr 2017Pulau Ketam, Selangor57SNA 244-S2*V. C*Skin mucus of red snapperHaemorrhagic liver and kidneyJune 2017Pulau Ketam, Selangor58SEA 206-S1*V. C*Skin mucus of Asian seabassHaemorrhage liverMay 2017Pulau Ketam, Selangor59GRO 230-L1*V. C*Liver of hybrid grouperLesion on whole body, pale liver and haemorrhage kidneyJune 2017Pulau Ketam, Selangor60PKGL28*V. C*Liver of hybrid grouperLesion on operculum and dorsal finNov 2017Kuala Gula, Perak61NS26*V. C*Spleen of hybrid grouperLesion on body and discolorationDis 2017Port Dickson, Negeri Sembilan62NS12*V. C*Spleen of hybrid grouperLesion on body and finsDis 2017Port Dickson, Negeri Sembilan63KL28*V. C*Liver of hybrid grouperLesion on body and fins, pale liver and spleen enlargedSept 2017Kota Bharu, Kelantan\**V.A*: *Vibrio alginolyticus*; *V.P*: *Vibrio parahaemolyticus*; *V.P*: *Vibrio harveyi*; *V.C*: *Vibrio campbelli*

AMP

:   Ampicillin

C

:   Chloramphenicol

CIP

:   Ciprofloxacin

CN

:   Gentamycin

CTX

:   Cefotaxime

E

:   Erythromycin

F

:   Nitrofurantoin

FEP

:   Cefepime

K

:   Kanamycin

KF

:   Cephalothin

MAR

:   Multiple antibiotic resistance

NA

:   Nalidixic acid

P

:   Penicillin G

S

:   Streptomycin

SXT

:   Trimethoprim/sulfamethoxazole

TE

:   Tetracycline

TSA

:   Tryptic soy agar

VA

:   Vancomycin
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